FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000398802> ?p ?o ?g. }

• W3000398802 endingPage "186" @default.
• W3000398802 startingPage "186" @default.
• W3000398802 abstract "Tivantinib, also known as ARQ-197, is a potent non-ATP competitive selective c-Met inhibitor currently under phase 3 clinical trial evaluation for liver and lung cancers. In this study, we explored factors that may lead to tivantinib resistance, especially in regards to its interaction with ATP-binding cassette super-family G member 2 (ABCG2). ABCG2 is one of the most important members of the ATP-binding cassette (ABC) transporter family, a group of membrane proteins that play a critical role in mediating multidrug resistance (MDR) in a variety of cancers, including those of the liver and lung. Tivantinib received a high score in docking analysis, indicating a strong interaction between tivantinib and ABCG2, and an ATPase assay indicated that tivantinib stimulated ABCG2 ATPase activity in a concentration-dependent manner. An MTT assay showed that ABCG2 overexpression significantly desensitized both the cancer cells and ABCG2 transfected-HEK293 cells to tivantinib and that this drug resistance can be reversed by ABCG2 inhibitors. Furthermore, tivantinib upregulated the protein expression of ABCG2 without altering the cell surface localization of ABCG2, leading to increased resistance to substrate drugs, such as mitoxantrone. Altogether, these data demonstrate that tivantinib is a substrate of ABCG2, and, therefore, ABCG2 overexpression may decrease its therapeutic effect. Our study provides evidence that the overexpression of ABCG2 should be monitored in clinical settings as an important risk factor for tivantinib drug resistance." @default.
• W3000398802 created "2020-01-23" @default.
• W3000398802 creator A5002736224 @default.
• W3000398802 creator A5007513557 @default.
• W3000398802 creator A5008998082 @default.
• W3000398802 creator A5014924040 @default.
• W3000398802 creator A5044867727 @default.
• W3000398802 creator A5060655886 @default.
• W3000398802 creator A5061425723 @default.
• W3000398802 creator A5075704903 @default.
• W3000398802 creator A5081785455 @default.
• W3000398802 creator A5081938413 @default.
• W3000398802 date "2020-01-12" @default.
• W3000398802 modified "2023-10-01" @default.
• W3000398802 title "Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance" @default.
• W3000398802 cites W1546346721 @default.
• W3000398802 cites W1787401899 @default.
• W3000398802 cites W179368301 @default.
• W3000398802 cites W1874417368 @default.
• W3000398802 cites W1905469811 @default.
• W3000398802 cites W1935761163 @default.
• W3000398802 cites W1964734895 @default.
• W3000398802 cites W1982230975 @default.
• W3000398802 cites W1985006115 @default.
• W3000398802 cites W1990371568 @default.
• W3000398802 cites W1990665786 @default.
• W3000398802 cites W1997394341 @default.
• W3000398802 cites W2037302753 @default.
• W3000398802 cites W2038306303 @default.
• W3000398802 cites W2044712457 @default.
• W3000398802 cites W2048047193 @default.
• W3000398802 cites W2053426133 @default.
• W3000398802 cites W2055904567 @default.
• W3000398802 cites W2072046272 @default.
• W3000398802 cites W2082177807 @default.
• W3000398802 cites W2089449278 @default.
• W3000398802 cites W2111842868 @default.
• W3000398802 cites W2119335520 @default.
• W3000398802 cites W2132268962 @default.
• W3000398802 cites W2140927361 @default.
• W3000398802 cites W2142024216 @default.
• W3000398802 cites W2164452916 @default.
• W3000398802 cites W2171223909 @default.
• W3000398802 cites W2225603648 @default.
• W3000398802 cites W2582477912 @default.
• W3000398802 cites W2750691704 @default.
• W3000398802 cites W2752435257 @default.
• W3000398802 cites W2791721408 @default.
• W3000398802 cites W2796451806 @default.
• W3000398802 cites W2796552195 @default.
• W3000398802 cites W2896638139 @default.
• W3000398802 cites W2898119028 @default.
• W3000398802 cites W2898566041 @default.
• W3000398802 cites W2898683460 @default.
• W3000398802 cites W2915631363 @default.
• W3000398802 cites W2921406196 @default.
• W3000398802 cites W2944437316 @default.
• W3000398802 cites W2964617822 @default.
• W3000398802 cites W2969837032 @default.
• W3000398802 cites W2975991016 @default.
• W3000398802 cites W42625690 @default.
• W3000398802 cites W2909963239 @default.
• W3000398802 doi "https://doi.org/10.3390/cancers12010186" @default.
• W3000398802 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7017082" @default.
• W3000398802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31940916" @default.
• W3000398802 hasPublicationYear "2020" @default.
• W3000398802 type Work @default.
• W3000398802 sameAs 3000398802 @default.
• W3000398802 citedByCount "31" @default.
• W3000398802 countsByYear W30003988022020 @default.
• W3000398802 countsByYear W30003988022021 @default.
• W3000398802 countsByYear W30003988022022 @default.
• W3000398802 countsByYear W30003988022023 @default.
• W3000398802 crossrefType "journal-article" @default.
• W3000398802 hasAuthorship W3000398802A5002736224 @default.
• W3000398802 hasAuthorship W3000398802A5007513557 @default.
• W3000398802 hasAuthorship W3000398802A5008998082 @default.
• W3000398802 hasAuthorship W3000398802A5014924040 @default.
• W3000398802 hasAuthorship W3000398802A5044867727 @default.
• W3000398802 hasAuthorship W3000398802A5060655886 @default.
• W3000398802 hasAuthorship W3000398802A5061425723 @default.
• W3000398802 hasAuthorship W3000398802A5075704903 @default.
• W3000398802 hasAuthorship W3000398802A5081785455 @default.
• W3000398802 hasAuthorship W3000398802A5081938413 @default.
• W3000398802 hasBestOaLocation W30003988021 @default.
• W3000398802 hasConcept C104317684 @default.
• W3000398802 hasConcept C114851261 @default.
• W3000398802 hasConcept C133936738 @default.
• W3000398802 hasConcept C149011108 @default.
• W3000398802 hasConcept C185592680 @default.
• W3000398802 hasConcept C2780035454 @default.
• W3000398802 hasConcept C44312359 @default.
• W3000398802 hasConcept C512196 @default.
• W3000398802 hasConcept C55493867 @default.
• W3000398802 hasConcept C71924100 @default.
• W3000398802 hasConcept C86803240 @default.
• W3000398802 hasConcept C89423630 @default.
• W3000398802 hasConcept C98274493 @default.

• next